Market Place
Sourcing Support
BioAegis Enrolls First Patient In ARDS Phase 2 Trial Of Gelsolin
22 Oct 2024 //
GLOBENEWSWIRE
BioAegis Enrolls First Patient In ARDS Trial Of Gelsolin
17 Oct 2024 //
GLOBENEWSWIRE
BioAegis To Present At MedInvest Biotech & Pharma Investor Conference
12 Sep 2024 //
GLOBENEWSWIRE
BioAegis Therapeutics Unveils Upcoming Clinical Study of Gelsolin
27 Feb 2024 //
GLOBENEWSWIRE
BioAegis Awarded $20 Million BARDA DRIVe Contract to Advance Gelsolin
16 Oct 2023 //
GLOBENEWSWIRE
BioAegis to Sponsor a Webinar, Below the Eyes of the Hippopotamus
10 May 2023 //
GLOBENEWSWIRE
BioAegis Announces Studies Exploring the Role of Inflammation Regulator Gelsolin
13 Apr 2023 //
GLOBENEWSWIRE
BioAegis Announces Clearance of IND for Inflammation Regulator Protein Gelsolin
26 Jan 2023 //
GLOBENEWSWIRE
BioAegis Leverages Gelsolin’s Broad Therap. Applicability Inflammatory Diseases
06 Jan 2023 //
GLOBENEWSWIRE
BioAegis Therapeutics Highlights Recent Article on Novel Host-Directed Protein
05 Dec 2022 //
GLOBENEWSWIRE
BioAegis Tx Completes $22M Institutional Sale of Equity
22 Mar 2022 //
GLOBENEWSWIRE
BioAegis Therapeutics Announces Appointment of Two New Corporate Board Members
17 Feb 2022 //
GLOBENEWSWIRE
BioAegis Therapeutics to Present “Conquering Pneumonia and Systemic Inflammation
30 Oct 2021 //
GLOBENEWSWIRE
Researchers Discover Previously Unknown Role of BioAegis’ Therapeutic Gelsolin
28 Sep 2021 //
GLOBENEWSWIRE
BioAegis Therapeutics to publish Use Case Study of a Critical COVID-19 Patient
27 Aug 2021 //
GLOBENEWSWIRE
BioAegis Awarded BARDA Contract to Advance Development of Gelsolin
29 Jun 2021 //
GLOBENEWSWIRE
BioAegis Therapeutics Completes Recruitment for Phase 2 Clinical Trial
15 Mar 2021 //
GLOBENEWSWIRE
BioAegis Therapeutics Expands Phase 2 COVID-19 Treatment Clinical Trial
16 Nov 2020 //
GLOBENEWSWIRE
COVID-19 therapeutics tracker
02 Oct 2020 //
RAPS
BioAegis Announces Study Indicating Gelsolin Treatment Improves Survival
04 Sep 2020 //
BIOSPACE
BioAegis Initiates Ph2 Trial of Its Inflammation Regulator, Gelsolin
06 Aug 2020 //
GLOBENEWSWIRE
BioAegis gets Spanish approval for Phase II Covid-19 trial of gelsolin
15 Jul 2020 //
CLINICALLTRIALSARENA
BioAegis Demonstrates Gelsolin Therapy Can Quell the Cytokine Storm and Promote
27 Apr 2020 //
GLOBENEWSWIRE
Copyright © 2024 LePro PharmaCompass OPC Private Limited, All rights reserved.